166 related articles for article (PubMed ID: 31857961)
21. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.
Tan J; Bissonnette R; Gratton D; Kerrouche N; Canosa JM
Eur J Dermatol; 2018 Aug; 28(4):502-508. PubMed ID: 30187864
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
23. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
[TBL] [Abstract][Full Text] [Related]
24. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
[TBL] [Abstract][Full Text] [Related]
25. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
26. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
27. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
28. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
29. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J
J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639
[TBL] [Abstract][Full Text] [Related]
30. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
Worret WI; Fluhr JW
J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
[TBL] [Abstract][Full Text] [Related]
31. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
Webster G; Thiboutot DM; Chen DM; Merikle E
Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
[TBL] [Abstract][Full Text] [Related]
32. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
Kawashima M; Sato S; Furukawa F; Matsunaga K; Akamatsu H; Igarashi A; Tsunemi Y; Hayashi N; Yamamoto Y; Nagare T; Katsuramaki T
J Dermatol; 2017 Jul; 44(7):774-782. PubMed ID: 28295516
[TBL] [Abstract][Full Text] [Related]
33. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
34. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Ting W
Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
36. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
Thiboutot D; Zaenglein A; Weiss J; Webster G; Calvarese B; Chen D
J Am Acad Dermatol; 2008 Nov; 59(5):792-800. PubMed ID: 18805603
[TBL] [Abstract][Full Text] [Related]
37. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
[TBL] [Abstract][Full Text] [Related]
38. Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel.
Jones TM; Jasper S; Alió Sáenz AB
Clin Pharmacol Drug Dev; 2013 Jan; 2(1):33-47. PubMed ID: 27121558
[TBL] [Abstract][Full Text] [Related]
39. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
[TBL] [Abstract][Full Text] [Related]
40. Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.
Richter C; Trojahn C; Hillmann K; Dobos G; Stroux A; Kottner J; Blume-Peytavi U
Skin Pharmacol Physiol; 2016; 29(1):1-8. PubMed ID: 26458265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
